Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
Hui Liu(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Yanyu Hu(China Pharmaceutical University), Lei Wang(China Pharmaceutical University), Chenxi Du(Sun Yat-sen University), Wenyuan Liu(China Pharmaceutical University), Tianyu Sun(China Pharmaceutical University), Weimin Qiu(China Pharmaceutical University), Feng Feng(China Pharmaceutical University), Chen Yao(Nanjing University of Chinese Medicine)
Cited by 84
Related Papers
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions
|Journal of Medicinal Chemistry|2019|203
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200